Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment

키워드

참고문헌 (40)

1. Schiffman M, "The carcinogenicity of human papillomavirus types reflects viral evolution", Virology, 337, pp.76~84 (2005)
2. Del Río-Ospina L, "Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors", Epidemiol Infect, 145, pp.1479~1490 (2017)
3. Sarian LO, "Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone(LLETZ)", J Clin Virol, 31, pp.270~274 (2004)
4. Massad LS, "2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors", Obstet Gynecol, 121, pp.829~846 (2013)
5. Melnikow J, "Cervical intraepithelial neoplasia outcomes after treatment : long-term follow-up from the British Columbia Cohort Study", J Natl Cancer Inst, 101, pp.721~728 (2009)
6. Venturoli S, "Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment", J Med Virol, 80, pp.1434~1440 (2008)
7. Alonso I, "Pre-and post-conization high-risk HPV testing predicts residual", recurrent disease in patients treated for CIN 2-3, 2006, pp.103, 631~636
8. Kocken M, "High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease : a systematic review and meta-analysis", Gynecol Oncol, 125, pp.500~507 (2012)
9. Kitchener HC, "HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia", BJOG, 115, pp.1001~1007 (2008)
10. Kocken M, "Risk of recurrent highgrade cervical intraepithelial neoplasia after successful treatment : a long-term multi-cohort study", Lancet Oncol, 12, pp.441~450 (2011)
11. Kim YT, "Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia", Int J Cancer, 126, pp.1903~1909 (2010)
12. Aerssens A, "Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia", Cytopathology, 20, pp.27~35 (2009)
13. Lubrano A, "Follow-up after LLETZ : a study of 682 cases of CIN 2-CIN 3 in a single institution", Eur J Obstet Gynecol Reprod Biol, 161, pp.71~74 (2012)
14. Song SH, "Persistent HPV infection after conization in patients with negative margins", Gynecol Oncol, 101, pp.418~422 (2006)
15. Gosvig CF, "Persistence and reappearance of high-risk human papillomavirus after conization", Gynecol Oncol, 131, pp.661~666 (2013)
16. Kwon MJ, "Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection", J Clin Virol, 59, pp.246~249 (2014)
17. Phillips S, "Comparison of the Roche Cobas® 4800 HPV assay to Roche Amplicor for detection of high-risk human papillomavirus", Eur J Clin Microbiol Infect Dis, 35, pp.1305~1307 (2016)
18. Jung S, "Clinical validation of Anyplex II HPV HR detection test for cervical cancer screening in Korea", Arch Pathol Lab Med, 140, pp.276~280 (2016)
19. Costa S, "Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization", Gynecol Oncol, 90, pp.358~365 (2003)
20. Stensen S, "Factors associated with type-specific persistence of high-risk human papillomavirus infection : A population-based study", Int J Cancer, 138, pp.361~368 (2016)
21. Kong TW, "Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix", Gynecol Oncol, 135, pp.468~473 (2014)
22. Dalstein V, "Persistence and load of highrisk HPV are predictors for development of high-grade cervical lesions : a longitudinal French cohort study", Int J Cancer, 106, pp.396~403 (2003)
23. Bae JH, "Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure", Int J Gynecol Cancer, 17, pp.1271~1277 (2007)
24. Schmitt M, "Abundance of multiple high-risk human papillomavirus(HPV)infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay", J Clin Microbiol, 48, pp.143~149 (2010)
25. Chaturvedi AK, "Human papillomavirus infection with multiple types : pattern of coinfection and risk of cervical disease", J Infect Dis, 203, pp.910~920 (2011)
26. Sherman ME, "Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3 : dominant impact of surrounding low-grade lesions", Cancer Epidemiol Biomarkers Prev, 12, pp.1038~1044 (2003)
27. Papoutsis D, "Does CIN2 have the same aggressive potential as CIN3? A Secondary analysis of high-grade cytology recurrence in women treated with cold-coagulation cervical treatment", Geburtshilfe Frauenheilkd, 77, pp.284~289 (2017)
28. Pirtea L, "Age and HPV type as risk factors for HPV persistence after loop excision in patients with high grade cervical lesions : an observational study", BMC Surg, 16, pp.70~ (2016)
29. Rizzuto I, "Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia", Int J Gynaecol Obstet, 141, pp.240~244 (2018)
30. 소경아, "Human papillomavirus genotype-specific risk in cervical carcinogenesis", Journal of Gynecologic Oncology, 30(4), pp.1~9 (2019), 대한부인종양학회[DOI]
31. Aho J, "Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women", J Infect Dis, 190, pp.46~52 (2004)
32. Kavanagh K, "Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16", 18 and closely related HPV types, 2014, pp.110, 2804~2811
33. 소경아, "Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea", 대한암예방학회지, 21(2), pp.104~109 (2016), 대한암예방학회[DOI]
34. Kang WD, "Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia(CIN2-3)especially in postmenopausal women", Menopause, 23, pp.81~86 (2016)
35. Söderlund-Strand A, "Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia", J Med Virol, 86, pp.634~641 (2014)
36. Kreimer AR, "Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3", Cancer Epidemiol Biomarkers Prev, 16, pp.11~16 (2007)
37. 남계헌, "Factors associated with HPV persistence after conization in patients with negative margins", Journal of Gynecologic Oncology, 20(2), pp.91~95 (2009), 대한부인종양학회
38. Park JY, "The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence", recurrence of cervical intraepithelial neoplasia after conization, 2008, pp.108, 549~554
39. Moscicki AB, "Updating the natural history of human papillomavirus and anogenital cancers", Vaccine, 30(Suppl 5), pp.F24~33 (2012)
40. Elfgren K, "Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia", Obstet Gynecol, 100, pp.965~971 (2002)

관련 논문AI추천